Darren Smith
Net worth: 118 976 $ as of 2026-07-30
Net worth: 118 976 $ as of 2026-07-30
Darren Smith is currently Director at Telix QSAM, Inc., Co-Managing Director at Rhine Pharma GmbH, Member at the Australian Institute of Co. Directors, and Group Chief Financial Officer at Telix Pharmaceuticals Ltd. since 2022.
Formerly, Mr. Smith was Global Chief Financial Officer & Secretary at Sirtex Medical Pty Ltd. from 2009 to 2019.
Education includes an undergraduate degree from the University of Western Sydney and an MBA from the Australian Graduate School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-28 | 11,921 ( 0% ) | 118 976 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director of Finance/CFO | 2022-07-30 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| SIRTEX MEDICAL LIMITED | Director of Finance/CFO | 2019-02-28 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of treatment for liver cancer | Commercial Services |
University of Western Sydney
University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Australian Graduate School of Management
Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions